A branch of Veolia Water Technology, ELGA LabWater has been working with scientists to design and deliver pure and ultrapure water for their research and lab work. AQUAVISTA™, Veolia Water Technologies’ platform of digital services, is now available with ELGA systems to support scientists and clinicians, freeing them to explore, create and build better societies.
Thanks to its intensive innovation programme, ELGA, as a major player into the Life Science and Healthcare market, has always matched clients expectations in terms of compliance and high standards of water quality, as well as ergonomic and reliable design.
Nora Ikene, Managing Director of ELGA Global Platform, stated: “The integration into ELGA products of AQUAVISTATM digital services allows end users to view, monitor and manage the efficiency of ELGA’s class leading pure and ultrapure water systems wherever they are globally”. She added: “ELGA has built a global reputation for quality, value and service within the most prestigious clinical and research organisations. Thanks to the disruptive solution developed by our scientists and engineers, our clients are able to optimize their system and service relationship on a daily basis. Real time access will ensure traceability, standard compliance and access our Labwater specialists worldwide”.
AQUAVISTATM is a digital platform based on Internet of Things, in-house water treatment expertise and advanced analytics, and contributes to laboratory effectiveness throughout the entire ELGA LabWater range. The remote monitoring water system minimizes interruption and intervention. Ever present vigilance delivers automated compliance, which in combination with unlimited operational expertise remove the distractions that undermine the pursuit of new knowledge and patient care.
“Focus groups have shown that the features that matter the most to users are reliability, cost of ownership and convenience, all features which AQUAVISTATM delivers on”, stated Aude Giard, Chief Digital Officer at Veolia Water Technologies. She continued: “In combination with AQUAVISTATM, ELGA LabWater systems will deliver greater research and clinical effectiveness, environmental footprint will be reduced and facilities will run more smoothly”.
AQUAVISTA™ at Nîmes University Hospital, France
The Biochemical & Molecular Biology laboratory at Nîmes University Hospital has been using ELGA solutions since 2013. Clinical chemical analysers need a constant, safe and compliant supply of water to produce and reproduce reliable diagnostic tests. Veolia’s offer meets this requirement for quality and traceability. It includes ELGA ’s Medica® Pro for water supply and a user interface with the AQUAVISTA™ portal for real-time water quality monitoring.
“Water quality is at the heart of the laboratory’s activity in order to ensure a constant quality service in the production of test results while guaranteeing the performance of our production. Over 1,000 samples are processed every day; 24/7 reproducibility of analytical processes is essential for rigorous monitoring of patients’ biological parameters”, explains Dr David-Paul De Brauwere, hospital practitioner at the Biochemical & Molecular Biology laboratory at CHU Nîmes, France.
AQUAVISTA™ for ELGA LabWater is designed with the maximum security
Data security is hard wired into the infrastructure of AQUAVISTATM. As a cloud service security is ensured by encryption and certificates, role-based user access profiles, and one-way communication from the equipment to the cloud. Cybersecurity compliance is regularly audited & guaranteed by standard protocols and industry-proven security architecture practices.
To find out more about ELGA LabWater, please visit the company's website: www.elgalabwater.com